VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Top Cited Papers
- 1 February 2001
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (2), 186-191
- https://doi.org/10.1038/84635
Abstract
Metastasis to local lymph nodes via the lymphatic vessels is a common step in the spread of solid tumors. To investigate the molecular mechanisms underlying the spread of cancer by the lymphatics, we examined the ability of vascular endothelial growth factor (VEGF)-D, a ligand for the lymphatic growth factor receptor VEGFR-3/Flt-4, to induce formation of lymphatics in a mouse tumor model. Staining with markers specific for lymphatic endothelium demonstrated that VEGF-D induced the formation of lymphatics within tumors. Moreover, expression of VEGF-D in tumor cells led to spread of the tumor to lymph nodes, whereas expression of VEGF, an angiogenic growth factor which activates VEGFR-2 but not VEGFR-3, did not. VEGF-D also promoted tumor angiogenesis and growth. Lymphatic spread induced by VEGF-D could be blocked with an antibody specific for VEGF-D. This study demonstrates that lymphatics can be established in solid tumors and implicates VEGF family members in determining the route of metastatic spread.Keywords
This publication has 30 references indexed in Scilit:
- Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular TumorsThe American Journal of Pathology, 1998
- Neutralising Antibodies to the Granulocyte Colony-stimulating Factor Receptor Recognise both the Immunoglobulin-like Domain and the Cytokine Receptor Homologous DomainGrowth Factors, 1997
- Antitumor Functions of Natural Killer Cells and Control of MetastasesMethods, 1996
- The role of natural killer cells in immune surveillance of cancerCurrent Opinion in Immunology, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Angiogenic FactorsScience, 1987
- Anti-AngiogenesisAnnals of Surgery, 1972
- The classification of cancer of the rectumThe Journal of Pathology and Bacteriology, 1932